Cochlear Implant Fitting Methods for Hearing Loss
(CALOS4 Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research shows that using personalized and optimized fitting methods for cochlear implants, which include objective data and machine-learning algorithms, can improve speech recognition and hearing outcomes. Additionally, studies indicate that combining behavioral and electrophysiological measures can help predict optimal comfort levels for cochlear implant users, leading to better hearing experiences.
12345The Categorical Loudness Scaling (CLS) Based Fitting treatment for cochlear implants is unique because it uses a method to scale loudness perception across different sound levels, allowing for more personalized and accurate adjustments of the implant's settings. This approach focuses on achieving normal loudness perception by defining specific loudness categories, which can be adjusted for each electrode, providing a tailored hearing experience for the user.
13678Eligibility Criteria
This trial is for adults over 18 who became deaf after age 2 and now have a CI600 or CI500 series cochlear implant. Participants must understand the language used in speech tests and agree to follow the study rules.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive both Categorical Loudness Scaling Based Fitting and Behavioural Fitting with 4 weeks experience of both MAPS
Follow-up
Participants are monitored for performance outcomes and further refinement of fitting methods